Patents by Inventor Gilles Quérat

Gilles Quérat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220227720
    Abstract: The present invention relates to a compound, or a dimer or a pharmaceutically acceptable salt or solvate of said compound or dimer, for use in a method for the treatment of a disease, disorder or condition caused by an RNA virus, said compound having the general structure shown in Formula (I).
    Type: Application
    Filed: May 6, 2020
    Publication date: July 21, 2022
    Inventors: Chris Meier, Matthias Winkler, Katharina Pfaff, Nora Constanze Fohrmann, Gilles Querat, Xavier de Lamballerie
  • Patent number: 10407667
    Abstract: The present invention relates to a method for rapid generation of an infectious RNA virus that completely eliminates the need of constructing a full-length c DNA, which covers the entire viral genome, cloning and propagating such full length c DNA.
    Type: Grant
    Filed: June 19, 2015
    Date of Patent: September 10, 2019
    Assignees: UNIVERSITÉ D'AIX-MARSEILLE, INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE)
    Inventors: Fabien Aubry, Antoine Nougairéde, Gilles Quérat, Xavier De Lamballerie, Ernest Andrew Gould, Lauriane De Fabritus
  • Publication number: 20180208907
    Abstract: The present invention relates to a method for rapid generation of an infectious RNA virus that completely eliminates the need of constructing a full-length c DNA, which covers the entire viral genome, cloning and propagating such full length c DNA.
    Type: Application
    Filed: June 19, 2015
    Publication date: July 26, 2018
    Inventors: Fabien Aubry, Antoine Nougairéde, Gilles Quérat, Xavier De Lamballerie, Ernest Andrew Gould, Lauriane De Fabritus